[PHARMA] YoY Cumulative Quarter Result on 30-Sep-2005 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
22-Nov-2005
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2005
Quarter
30-Sep-2005 [#3]
Profit Trend
QoQ- 33.38%
YoY- -30.9%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Revenue 977,403 891,166 790,927 692,222 599,214 465,987 455,450 13.55%
PBT 66,103 54,326 27,852 41,415 59,514 48,177 49,883 4.79%
Tax -22,616 -19,055 -10,643 -13,462 -22,047 -16,916 -19,321 2.65%
NP 43,487 35,271 17,209 27,953 37,467 31,261 30,562 6.04%
-
NP to SH 42,242 34,011 15,974 25,890 37,467 31,261 30,562 5.53%
-
Tax Rate 34.21% 35.08% 38.21% 32.51% 37.05% 35.11% 38.73% -
Total Cost 933,916 855,895 773,718 664,269 561,747 434,726 424,888 14.01%
-
Net Worth 374,390 335,831 323,006 272,364 255,778 211,412 172,567 13.76%
Dividend
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Div 19,254 16,042 12,299 14,389 - 6,011 1,250 57.67%
Div Payout % 45.58% 47.17% 77.00% 55.58% - 19.23% 4.09% -
Equity
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Net Worth 374,390 335,831 323,006 272,364 255,778 211,412 172,567 13.76%
NOSH 106,968 106,952 106,955 102,778 101,098 100,195 50,019 13.49%
Ratio Analysis
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
NP Margin 4.45% 3.96% 2.18% 4.04% 6.25% 6.71% 6.71% -
ROE 11.28% 10.13% 4.95% 9.51% 14.65% 14.79% 17.71% -
Per Share
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
RPS 913.73 833.23 739.49 673.51 592.70 465.08 910.54 0.05%
EPS 39.49 31.80 14.93 25.19 37.06 31.20 61.10 -7.00%
DPS 18.00 15.00 11.50 14.00 0.00 6.00 2.50 38.91%
NAPS 3.50 3.14 3.02 2.65 2.53 2.11 3.45 0.23%
Adjusted Per Share Value based on latest NOSH - 104,012
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
RPS 67.82 61.83 54.88 48.03 41.58 32.33 31.60 13.56%
EPS 2.93 2.36 1.11 1.80 2.60 2.17 2.12 5.53%
DPS 1.34 1.11 0.85 1.00 0.00 0.42 0.09 56.78%
NAPS 0.2598 0.233 0.2241 0.189 0.1775 0.1467 0.1197 13.77%
Price Multiplier on Financial Quarter End Date
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Date 30/09/08 28/09/07 29/09/06 30/09/05 30/09/04 30/09/03 30/09/02 -
Price 3.24 3.27 3.98 4.95 4.77 4.55 7.68 -
P/RPS 0.35 0.39 0.54 0.73 0.80 0.98 0.84 -13.56%
P/EPS 8.20 10.28 26.65 19.65 12.87 14.58 12.57 -6.86%
EY 12.19 9.72 3.75 5.09 7.77 6.86 7.96 7.35%
DY 5.56 4.59 2.89 2.83 0.00 1.32 0.33 60.04%
P/NAPS 0.93 1.04 1.32 1.87 1.89 2.16 2.23 -13.55%
Price Multiplier on Announcement Date
30/09/08 30/09/07 30/09/06 30/09/05 30/09/04 30/09/03 30/09/02 CAGR
Date 24/11/08 22/11/07 13/11/06 22/11/05 26/11/04 14/11/03 22/11/02 -
Price 3.35 3.42 3.65 4.82 4.77 5.00 7.36 -
P/RPS 0.37 0.41 0.49 0.72 0.80 1.08 0.81 -12.23%
P/EPS 8.48 10.75 24.44 19.13 12.87 16.03 12.05 -5.68%
EY 11.79 9.30 4.09 5.23 7.77 6.24 8.30 6.01%
DY 5.37 4.39 3.15 2.90 0.00 1.20 0.34 58.33%
P/NAPS 0.96 1.09 1.21 1.82 1.89 2.37 2.13 -12.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment